Medicus Total Cash From Financing Activities from 2010 to 2025

MDCX Stock  USD 2.90  0.90  23.68%   
Medicus Pharma Total Cash From Financing Activities yearly trend continues to be fairly stable with very little volatility. Total Cash From Financing Activities is likely to outpace its year average in 2025. During the period from 2010 to 2025, Medicus Pharma Total Cash From Financing Activities regression line of annual values had r-squared of  0.55 and arithmetic mean of  1,558,883. View All Fundamentals
 
Total Cash From Financing Activities  
First Reported
2010-12-31
Previous Quarter
6.5 M
Current Value
6.8 M
Quarterly Volatility
2.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Medicus Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medicus Pharma's main balance sheet or income statement drivers, such as Interest Expense of 892.5 K, Selling General Administrative of 3.4 M or Total Revenue of 0.0, as well as many indicators such as . Medicus financial statements analysis is a perfect complement when working with Medicus Pharma Valuation or Volatility modules.
  
Check out the analysis of Medicus Pharma Correlation against competitors.

Latest Medicus Pharma's Total Cash From Financing Activities Growth Pattern

Below is the plot of the Total Cash From Financing Activities of Medicus Pharma Ltd over the last few years. It is Medicus Pharma's Total Cash From Financing Activities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medicus Pharma's overall financial position and show how it may be relating to other accounts over time.
Total Cash From Financing Activities10 Years Trend
Slightly volatile
   Total Cash From Financing Activities   
       Timeline  

Medicus Total Cash From Financing Activities Regression Statistics

Arithmetic Mean1,558,883
Geometric Mean139,733
Coefficient Of Variation153.81
Mean Deviation1,769,845
Median882,385
Standard Deviation2,397,650
Sample Variance5.7T
Range6.8M
R-Value0.74
Mean Square Error2.8T
R-Squared0.55
Significance0.001
Slope373,795
Total Sum of Squares86.2T

Medicus Total Cash From Financing Activities History

20256.8 M
20246.5 M
20235.6 M
20221.2 M
2018882.4 K
2017106.6 K

About Medicus Pharma Financial Statements

Medicus Pharma investors use historical fundamental indicators, such as Medicus Pharma's Total Cash From Financing Activities, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Medicus Pharma. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Cash From Financing Activities6.5 M6.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Medicus OTC BB Equity Analysis

When running Medicus Pharma's price analysis, check to measure Medicus Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicus Pharma is operating at the current time. Most of Medicus Pharma's value examination focuses on studying past and present price action to predict the probability of Medicus Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicus Pharma's price. Additionally, you may evaluate how the addition of Medicus Pharma to your portfolios can decrease your overall portfolio volatility.